Organisation paid for research Program year 2025 Source: CMS Open Payments

Gordon Schanzlin New Vision

Neither a doctor nor a teaching hospital

Research payments

$719,442

690 payments

Through program year 2025, Gordon Schanzlin New Vision is reported as receiving $719,442 in research payments, across 690 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$62,658	2
2024	Research	$40,653	42
2023	Research	$80,272	9
2022	Research	$10,932	24
2021	Research	$201,957	309
2020	Research	$246,665	252
2019	Research	$76,304	52

Breakdown

Who paid Research payments · program years 2019–2025

Alcon Research LLC $671,789 689 payments
AbbVie, Inc. $47,653 1 payment

Studies the money was for Research payments · program years 2019–2025

Pivotal Trial of WaveLight EX500 Excimer Laser System for the Correction of Myopia with and without Astigmatism Using InnovEyes in Conjunction with InnovEyes sightmap $403,079 548 payments
The Effectiveness of Systane PRO in providing relief from multiple symptoms of dry eye disease, and its impact on daily functioning and overall comfort in dry eye subjects? $62,658 2 payments
Next Generation Cataract Surgery Study $61,473 48 payments
Improved near vision and intermediate without loss of binocular distance vision using AGN190584 in subjects utilizing single contact lenses for distance vision correction both eyes $47,653 1 payment
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study $41,065 44 payments
Improved efficiency in total ultrasound time, total fluid volume used and total case time using the Active Sentry handpiece for the Centurion cataract system. $25,000 1 payment
Long term results with the iLux device $24,500 1 payment
Comparison between iLux and LipiFlow in the treatment of MGD 12 month study $15,382 29 payments
Improved efficiency when using the Active Sentry hand-piece for the Centurion cataract system $12,500 1 payment
Performance Evaluation and Safety Assessment of Next Generation Phaco Vitreoretinal Equipment - AUS $10,800 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.